Patent · US Active

Compositions comprising thienopyrimidine and thienopyridine compounds and methods of use thereof

US9216993B2 · kind B2 · utility

23Cited by
1References
54Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 10, 2014
Grant dateDec 22, 2015
Priority date
Expiry dateMar 10, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates generally to thienopyrimidine and thienopyridine compounds and methods of use thereof. In particular embodiments, the present disclosure provides compositions comprising thienopyrimidine and thienopyridine compounds of Formula 4:and methods of use to inhibit the interaction of menin with MLL1, MLL2 and MLL-fusion oncoproteins.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.